Advanced Search

Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
F 3.04 2.01% 0.06
ODT closed down 2.61 percent on Wednesday, May 12, 2021, on 16 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
7 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ODT trend table...
Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 2.01%
New 52 Week Low Weakness 2.01%
Outside Day Range Expansion 2.01%
Down 3 Days in a Row Weakness 2.01%
Oversold Stochastic Weakness 2.01%
Narrow Range Bar Range Contraction -0.65%
Oversold Stochastic Weakness -0.65%
Boomer Sell Setup Bearish Swing Setup -2.25%
Narrow Range Bar Range Contraction -2.25%
NR7 Range Contraction -2.25%
Older End-of-Day Signals for ODT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 1 hour ago
Up 3% about 3 hours ago
Up 2% about 3 hours ago
Up 1% about 3 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Pharmaceutical Spotlight Innovation Urbandale

Is ODT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
May 6 Odonate Therapeutics (ODT) Enters Oversold Territory
Apr 27 Odonate Therapeutics: Lessons Learned
Apr 13 25 Stocks Moving in Tuesday's Pre-Market Session
Apr 11 3 Critical Things Investors Should Look for Before Buying Clinical-Stage Biotech Stocks
Apr 9 Odonate Therapeutics (ODT) is Oversold: Can It Recover?
Mar 29 63 Biggest Movers From Friday
Mar 27 The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
Mar 26 The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
Mar 24 Do Options Traders Know Something About Odonate Therapeutics (ODT) Stock We Don't?
Mar 23 The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO
See more ODT news...

Indicators

Indicator Value
52 Week High 46.4999
52 Week Low 2.95
Average Volume 5,299,482
200-Day Moving Average 16.74
50-Day Moving Average 7.28
20-Day Moving Average 3.29
10-Day Moving Average 3.15
Average True Range 0.39
ADX 40.5
+DI 14.86
-DI 34.36
Chandelier Exit (Long, 3 ATRs ) 2.62
Chandelier Exit (Short, 3 ATRs ) 4.13
Upper Bollinger Band 3.68
Lower Bollinger Band 2.89
Percent B (%b) 0.11
BandWidth 23.80
MACD Line -1.02
MACD Signal Line -1.35
MACD Histogram 0.3312
Fundamentals Value
Market Cap 114.82 Million
Num Shares 38.5 Million
EPS -4.46
Price-to-Earnings (P/E) Ratio -0.67
Price-to-Sales 0.00
Price-to-Book 3.72
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.30
Resistance 3 (R3) 3.32 3.24 3.24
Resistance 2 (R2) 3.24 3.16 3.23 3.22
Resistance 1 (R1) 3.11 3.11 3.07 3.09 3.21
Pivot Point 3.03 3.03 3.01 3.02 3.03
Support 1 (S1) 2.90 2.95 2.86 2.88 2.75
Support 2 (S2) 2.82 2.90 2.81 2.74
Support 3 (S3) 2.69 2.82 2.72
Support 4 (S4) 2.67